AKT1 and cancer: As demonstrated in the Fig. 7A, cMAP signaling pathway, cell adhesion molecules, ECM-receptor interaction, proteoglycans in cancer, MAPK, PRAR, and PI3K-Akt signaling pathways were significantly enriched in the high-risk group.